Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4Postgastrectomy Syndromes 1Neoplasms 1Metabolic Syndrome 1Metabolic Diseases 1Intestinal Obstruction 1Insulin Resistance 1Gastroesophageal Reflux 1Diabetes Mellitus 1

Interventions

fludarabine 2Busulfan 2thymoglobulin 1fludarabine phosphate 1bicalutamide 1Testosterone 1Saline Solution 1Powders 1Nutrition Assessment 1Metformin 1Mesna 1Melphalan 1Influenza Vaccines 1Honey 1Heparin 1Gonadotropin-Releasing Hormone 1Gastric Bypass 1Exercise 1Eating 1Cyclophosphamide 1Clofarabine 1Caloric Restriction 1Antineoplastic Agents 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Metabolic Diseases × Gastric Bypass × Clear all
NCT01714622 2019-03-29

Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance

Yonsei University

Withdrawn
Gastrointestinal

Insulin Resistance, Metabolic Diseases, Stomach Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡